Clinical Trial Update: Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)

View source ↗

Summary

APPEAR is a clinical trial evaluating amino acid PET-based response assessment in IDH-mutant gliomas and is currently recruiting, sponsored by LMU Klinikum.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Idh-mutant Glioma
• Oligodendroglioma

Snippet

Sponsor: LMU Klinikum | Conditions: IDH-mutant Glioma (Oligodendroglioma, Astrocytoma) | Status: RECRUITING